	Despesas De Vendas E Administração		Data
Acadia Pharmaceuticals	USD 146.73M	21.82M	2025-12
Alaunos Therapeutics	USD 585K	260K	2025-09
ANI Pharmaceuticals	USD 82.79M	6.13M	2025-12
Ardelyx	USD 83.61M	378K	2025-09
Assertio Holdings	USD 16.73M	1.66M	2024-09
Aurora Cannabis	CAD 41.79M	3.84M	2025-09
BioMarin Pharmaceutical	USD 322.21M	98.79M	2025-12
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Canopy Growth	CAD 29.53M	999K	2025-09
Corcept Therapeutics	USD 114.74M	7.77M	2025-12
Eli Lilly	USD 3.13B	391.3M	2025-12
Esperion Therapeutics	USD 39.98M	4.21M	2024-09
J&J	USD 6.75B	831M	2025-12
Knight Therapeutics	CAD 25.48M	119K	2024-09
Lexicon Pharmaceuticals	USD 39.19M	7.13M	2024-06
Merck	USD 2.85B	215M	2025-12
Nektar Therapeutics	USD -0.18	0.07	2024-09
Novartis	USD 3.31B	134M	2025-09
Novartis	USD 3.3B	137M	2025-09
Omeros	USD 11.32M	2.48M	2024-09
Pacira	USD 91.87M	70K	2025-12
Pfizer	USD 4.08B	894M	2025-12
Supernus Pharmaceuticals	USD 122.39M	57.29M	2025-12
TG Therapeutics	USD 50.73M	12.64M	2025-12

Corcept Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.